DeepMed Research

University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease

Phase 4

Terminated

Conditions: Thyroid Eye Disease

Interventions: Drug: Hyaluronic Acid Gel injection
Drug: Saline injection

First Posted Date: 2012-11-30

Last Posted Date: 2021-10-04

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 2

Registration Number: NCT01738243

Locations: 🇺🇸
Jules Stein Eye Institute, Los Angeles, California, United States
🇺🇸
The Jules Stein Eye Institute at UCLA, Los Angeles, California, United States

Can Acetaminophen Given 1-2 Hours to Children Before Ear Tube Surgery Reduce Agitation After Anesthesia?

Phase 4

Terminated

Conditions: Emergence Agitation
Pain

Interventions: Drug: Acetaminophen

First Posted Date: 2012-11-29

Last Posted Date: 2016-10-21

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 108

Registration Number: NCT01737593

Locations: 🇺🇸
University of California, Los Angeles Medical Center, Los Angeles, California, United States

Neural and Physiological Responses to Real-World Experiences

Not Applicable

Completed

Conditions: Gene Expression

Interventions: Behavioral: Writing about people
Other: Writing about places, objects

First Posted Date: 2012-11-07

Last Posted Date: 2015-12-11

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 70

Registration Number: NCT01723410

Locations: 🇺🇸
UCLA CTRC & Brain Mapping Center, Los Angeles, California, United States

Expedited Partner Therapy for MSM in Peru

Not Applicable

Completed

Conditions: Chlamydia
Gonorrhea

Interventions: Behavioral: EPT

First Posted Date: 2012-11-02

Last Posted Date: 2014-08-06

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 165

Registration Number: NCT01720654

Locations: 🇵🇪
Asociacion Civil Impacta Salud y Educacion, Lima, Peru

Partner Notification Strategies for MSM in Peru

Not Applicable

Completed

Conditions: Partner Notification Following STI Diagnosis

Interventions: Behavioral: Internet and Referral Card
Behavioral: Internet
Behavioral: Referral Card

First Posted Date: 2012-11-02

Last Posted Date: 2014-08-06

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 370

Registration Number: NCT01720641

Locations: 🇵🇪
Asociacion Civil Impacta Salud y Educacion, Lima, Peru

Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis

Phase 4

Withdrawn

Conditions: Apoptotic DNA Damage
Rheumatoid Arthritis
T-cell Lymphocytosis

Interventions: Other: Group 2 (DMARDS treated group)
Drug: Group 1 or Orencia treated group

First Posted Date: 2012-10-31

Last Posted Date: 2016-05-11

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT01717846

Locations: 🇺🇸
Univerity of California at Los Angeles, Los Angeles, California, United States

Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab

Phase 4

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: Tocilizumab

First Posted Date: 2012-10-31

Last Posted Date: 2019-05-15

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 74

Registration Number: NCT01717859

Locations: 🇺🇸
UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles, California, United States

Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation

Phase 2

Completed

Conditions: Severe Mood Dysregulation

Interventions: Drug: lisdexamfetamine
Drug: Placebo
Drug: fluoxetine

First Posted Date: 2012-10-25

Last Posted Date: 2018-02-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 34

Registration Number: NCT01714310

Locations: 🇺🇸
UCLA Semel Institute, Los Angeles, California, United States

Promotora-based Latino Family CVD Risk Reduction

Phase 2

Completed

Conditions: Cancer
Heart Disease

Interventions: Behavioral: Cancer early detection
Behavioral: Home environs-based lifestyle counseling

First Posted Date: 2012-10-25

Last Posted Date: 2023-10-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 204

Registration Number: NCT01714271

Locations: 🇺🇸
Roybal Comprehensive Health Center, Los Angeles, California, United States

Attention Training for Childhood Obsessive Compulsive Disorder: An Open Case Series

Phase 1

Completed

Conditions: Obsessive Compulsive Disorder

Interventions: Behavioral: Attention Modification Program

First Posted Date: 2012-10-16

Last Posted Date: 2017-01-16

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 6

Registration Number: NCT01708226

Locations: 🇺🇸
University of California Los Angeles, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy